ANIK News 46.84 05/14/2014 04:27:23 Anika Therapeutics Inc (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Anika Therapeutics Inc (ANIK) 46.84 $ANIK

IBD 50 High-Growth Shares Remain In Correction
at Investor's Business Daily - Fri May 09, 5:55PM CDT
Weather across America may have more or less returned to normal. Thoughts of winter are drifting further behind. But there are still few signs of a spring thaw in the market for high-growth, high-priced stocks. While the Dow Jones industrial average...

Anika Therapeutics Shares Up 31.1% Since SmarTrend's Buy Recommendation (ANIK)
Comtex SmarTrend(R) - Wed May 07, 9:42AM CDT
SmarTrend identified an Uptrend for Anika Therapeutics (NASDAQ:ANIK) on February 21st, 2014 at $34.68. In approximately 3 months, Anika Therapeutics has returned 31.10% as of today's recent price of $45.46.

Stocks Finish Higher After Early Sell-Off
at Investor's Business Daily - Mon May 05, 3:21PM CDT
Stocks finished modestly higher Monday after opening down on jitters over violence in Ukraine and weak Chinese factory data. The Nasdaq rose 0.3%, the S&P 500 0.2% and the Dow Jones industrial average 0.1%. Volume was lower across the board,...

Insider Trading Alert - ANIK, TRLA And AMED Traded By Insiders
at The Street - Mon May 05, 9:15AM CDT
Stocks with insider trader activity include ANIK, TRLA and AMED

5 Stocks Ready to Break Out
at The Street - Fri May 02, 12:53PM CDT
These stocks look poised to break out and trade higher from current levels.

Stocks Close Mixed; Nasdaq Up For Third Straight Day
at Investor's Business Daily - Thu May 01, 3:20PM CDT
Stocks gave up early gains Thursday to finish mixed, with the Nasdaq hanging on to a narrow gain. The day marked the third straight advance for the Nasdaq. The Nasdaq rose 0.3%; the S&P 500 was down a hair and the Dow Jones industrial average fell...

Stocks Turn Mixed: Valeant Retakes 50-Day Line
at Investor's Business Daily - Thu May 01, 12:35PM CDT
Stocks lost steam and turned mixed Thursday afternoon, as indexes wavered amid a barrage of earnings reports and mixed economic data. The Nasdaq was up 0.6% after rising 0.8% earlier. The S&P 500 edged up 0.1%. But the Dow Jones industrial average...

4 Big-Volume Stocks in Breakout Territory
at The Street - Thu May 01, 8:18AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.

Stocks Rise In Higher Volume; Anika Jumps On Earnings
at Investor's Business Daily - Wed Apr 30, 4:04PM CDT
Stocks rose Wednesday, with the Dow Jones industrial average closing at a new all-time high, after the Federal Reserve expressed optimism about the economy. The Dow, the S&P 500 and the Nasdaq each climbed 0.3% in the stock market today. The Nasdaq...

Shares of ANIK Up 17.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Apr 30, 9:20AM CDT
SmarTrend identified an Uptrend for Anika Therapeutics (NASDAQ:ANIK) on February 21st, 2014 at $34.68. In approximately 2 months, Anika Therapeutics has returned 17.16% as of today's recent price of $40.63.

Anika Therapeutics achieves higher net income of USD15.0m in Q1 2014
M2 - Wed Apr 30, 5:18AM CDT
Tissue protection company Anika Therapeutics (NasdaqGS:ANIK) stated on Tuesday its net income of USD15.0m (USD0.97 per diluted share) for the first quarter ended 31 March 2014.

ANIKA THERAPEUTICS'
at Investor's Business Daily - Tue Apr 29, 5:42PM CDT
ANIKA THERAPEUTICS' (ANIK) Q1 EPS soared to 97 cents vs. 20 cents a year ago. The biotech's revenue jumped 123% to $34 mil, above views. Shares rose 5.1% to 42.99.

Anika Therapeutics Reports First Quarter 2014 Financial Results
Business Wire - Tue Apr 29, 3:06PM CDT
--Total Revenue Grows 123% to $34 Million

Some IBD 50 Stocks May Be Forming Bases
at Investor's Business Daily - Mon Apr 28, 5:42PM CDT
The correction has beaten up many IBD 50 stocks. Many are below their 50-day moving averages and well off their highs. But there's a silver lining. Some look like they're building new bases. Facebook (FB) reported earnings after the close Wednesday...

Nasdaq Recovers After Early Weakness; Apple Rallies Again
at Investor's Business Daily - Mon Apr 28, 3:28PM CDT
The Dow Jones industrial average and S&P 500 ended higher Monday, and the Nasdaq recovered early losses in a resilient performance. At the close, the Nasdaq fell less than 0.1% lower after being down by as much as 1.5%. It's still holding above its...

IBD 50: Actavis, Spirit Lead 5 Top Earnings On Tap
at Investor's Business Daily - Sat Apr 26, 7:02AM CDT
The market is in correction with tensions in Ukraine weighing on sentiment, but several top-rated companies are slated to report earnings this week. Most of these stocks are holding up relatively well. Spirit Airlines (SAVE), ranked No. 2 on the IBD...

Uptrend Call Working As Anika Therapeutics Stock Rises 21.1% (ANIK)
Comtex SmarTrend(R) - Tue Apr 22, 5:07PM CDT
SmarTrend identified an Uptrend for Anika Therapeutics (NASDAQ:ANIK) on February 21st, 2014 at $34.68. In approximately 2 months, Anika Therapeutics has returned 21.10% as of today's recent price of $41.99.

Stocks Back Out Of Early Gains; SanDisk, Chipotle Rise
at Investor's Business Daily - Thu Apr 17, 9:32AM CDT
A long roster of earnings reports launched stocks higher, but gains quickly faded in heavy trade Thursday. The Nasdaq, S&P 500 and Dow Jones industrial average reversed early gains in the stock market today and were down 0.1% each. Volume surged at...

Anika Therapeutics Announces Date of First-Quarter 2014 Financial Results Conference Call
Business Wire - Wed Apr 16, 4:08PM CDT
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2014 financial results after the close of the market on Tuesday, April 29, 2014. The company plans to hold a conference call the next day, Wednesday, April 30 at 9:00 a.m. ET to discuss its financial results, business highlights and outlook. In addition, the company will answer questions concerning business and financial developments and trends, and other business and financial matters affecting the company, some of the responses to which may contain information that has not been previously disclosed.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Century Lithium Clears a Crucial Nevada Permit Gate

Updated Category News Views 65

Permitting news rarely rings a cash register, but it can stop one from being bolted shut. Century Lithium has received confirmation from the Bureau of Land Management’s Tonopah Field Office that baseline studies for its wholly owned Angel Island lithium project in Esmeralda County, Nevada, are complete. The agency also set the project on the Environmental Impact...

Continue Reading
Global-E Faces Fresh Scrutiny After Muted Quarterly Outlook

Updated Category News Views 28

A guidance bump that barely clears the curb can still wreck a stock. That is the unpleasant read-through from Global-E Online's third-quarter 2026 report: revenue guidance went higher, but not high enough to persuade investors that the business was pulling away from expectations. Shares fell after the release, and a securities-law investigation announced November 19 has...

Continue Reading
Tigerlily Takes Its Advocacy Model to Ovarian Cancer

Updated Category News Views 182

Ovarian cancer has a nasty habit of hiding behind symptoms people are taught to shrug off. Persistent bloating or pelvic pain can look like any number of ordinary problems, and that ambiguity is exactly why practical, trusted education matters. Tigerlily Foundation's new ovarian cancer initiative is not a flashy breakthrough claim. It is a grounded attempt to help women...

Continue Reading
Blue Moon Closes Turner Deal, Eyes Nevada Mill Plan

Updated Category News Views 52

A shuttered Oregon copper-gold deposit just became part of Blue Moon’s puzzle, and the real question is whether the pieces can ever be made to fit cheaply enough to matter. Turner Adds a Nearby VMS Angle Blue Moon Metals has completed its acquisition of the Turner copper-gold deposit in O’Brien, Oregon, from Gold Coast Mining. The formal closing follows the September...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 120

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
DoorDash Grocery Tools Need a Hard Look Before Checkout

Updated Category News Views 107

A grocery cart built in thirty seconds can still nick your wallet all week. That is the part buried beneath the convenience pitch around DoorDash's grocery tools: planning is useful, but convenience only earns its keep when the final basket, delivery charge, substitutions, and timing actually line up. The 2026 review from Expert Consumers highlights features that are...

Continue Reading
ACOLT Bets on Gold, Craft, and a Sci-Fi Story World

Updated Category News Views 96

A gold pendant moonlighting as a plot device is not the usual luxury pitch, and thank goodness for that. ACOLT, the Denver-based men's fine jewelry house founded by Colton Hindle, plans an international December 2026 launch of its Gold Collection alongside CHRYSON Volume 1: The Arrival, an original science-fiction comic. The actual hand-forged pieces are meant to show up...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 116

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading
Compounded Peptides Demand Clearer FDA Status Answers

Updated Category News Views 92

Peptide talk has gotten muddled enough to make plain English feel revolutionary. The central point in the HelloNation article featuring wellness expert Andres Giraldo is straightforward: a compounded peptide is not FDA approved in the same product-specific manner as a commercially manufactured drug. That is not a small semantic wrinkle, and it should not be buried beneath...

Continue Reading
Vail Resorts Bets on Music to Deepen Epic Pass Demand

Updated Category News Views 119

A bass drop at 11,000 feet is not merely a party trick when you run 42 mountain resorts. Vail Resorts is putting live music, après programming and destination events squarely beside skiing and riding for winter 2026-27, and the business logic is pretty plain: give people another reason to buy early, stay longer and return with friends. For investors watching MTN, this is...

Continue Reading

Top 5 Most Recently Viewed Articles

Siebert Financial Secures $100 Million for Innovation and Growth

Updated Category News Views 177

Siebert Financial Initiates Strategic Funding Initiative Siebert Financial Corp. (NASDAQ: SIEB) has taken a significant step by announcing the effective declaration of its shelf registration statement on Form S-3 by the SEC. This move permits the company to raise an impressive $100 million through a variety of securities offerings. Enhancing Financial Flexibility and...

Continue Reading
BTQ Technologies Launches Léonne: A New Era in Blockchain Security

Updated Category News Views 250

BTQ Technologies Introduces Léonne Framework BTQ Technologies Corp. is making waves in the blockchain industry with the unveiling of Léonne, a groundbreaking consensus framework that integrates trust modeling, network analysis, and quantum-resistant cryptography into a cohesive and modular system. This innovative approach positions Léonne as the first of its kind,...

Continue Reading
Annovis Bio Welcomes Matthew Peterson, Ph.D., to Lead Clinical Trials

Updated Category News Views 231

Matthew Peterson, Ph.D., Joins Annovis Bio as Senior Clinical Scientist Annovis Bio Inc. (NYSE: ANVS) is making headlines with the recent addition of Dr. Matthew Peterson as Senior Clinical Scientist. This strategic appointment comes at a critical juncture for the company, which is dedicated to developing innovative therapies targeting neurodegenerative disorders...

Continue Reading
Ironwood's Strategic Shift: Apraglutide Development Focus

Updated Category News Views 252

Ironwood Pharmaceuticals Outlines Strategic Focus on Apraglutide Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a leading biotechnology company committed to developing innovative therapies for gastrointestinal and rare diseases, has announced a profound strategic shift towards advancing apraglutide, specifically aimed at treating patients with short bowel syndrome (SBS)...

Continue Reading
Chamberlain Group Elevates Home Security with Innovative Smart Lock

Updated Category News Views 341

Chamberlain Group Unveils the Next Generation of Home Security In a groundbreaking move, Chamberlain Group (CG) has introduced the myQ Secure View 3-in-1 Smart Lock, a device that not only acts as a smart lock but also integrates a doorbell and camera. This innovative product marks a significant shift for the company as it extends its reach from garage door innovations to...

Continue Reading